NEW YORK (Thomson Financial) - Catalyst Pharmaceutical Partners Inc. Tuesday
said it has filed a shelf registration statement with the Securities and
Exchange Commission for a public offering of up to a total of $30 million in
stock.
The shelf registration statement is intended to provide the company with
flexibility to raise funds from the offering of its common stock, Catalyst said.
There are no immediate plans to raise any funds.
Catalyst shares closed at $3.42 on Monday.
Christie Rizk
cr/vj
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|